SCHEMBL31472286

SCHEMBL31472286

CN(C)c1cnc2ccc(-c3nc(NC4CCN(S(=O)(=O)C5CC5)CC4)ncc3F)cc2n1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CDK6 Q00534 16/20 0.52
PIM1 P11309 4/20 0.52
CDK2 P24941 5/20 0.50
CCNE1 P24864 4/20 0.50
CDK1 P06493 3/20 0.50
CCNB1 P14635 3/20 0.50
CCNB2 O95067 1/20 0.50
CCNE2 O96020 1/20 0.50
CDK5 Q00535 1/20 0.50
CDK5R1 Q15078 1/20 0.50
CCNB3 Q8WWL7 1/20 0.50
CDK4 P11802 6/20 0.45
CCND1 P24385 6/20 0.45
CCNT1 O60563 3/20 0.45
CDK7 P50613 3/20 0.45
CDK9 P50750 3/20 0.45
CCNH P51946 3/20 0.45
MNAT1 P51948 3/20 0.45
CCNA2 P20248 1/20 0.45
PIM3 Q86V86 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31472291 0.92 CDK6 (0.55) CDK6PIM1CDK2CCNE1CDK1
SCHEMBL29233656 0.85 CDK6 (0.58) CDK6PIM1CDK2CDK4CCND1
SCHEMBL31472294 0.85 CDK6 (0.58) CDK6PIM1CDK2CDK4CCND1
SCHEMBL31472289 0.84 CDK2 (0.58) CDK6PIM1CDK2CCNE1CDK1
SCHEMBL29233639 0.84 CDK2 (0.58) CDK6PIM1CDK2CCNE1CDK1
SCHEMBL31472290 0.83 CDK6 (0.62) CDK6PIM1CDK2CDK4CCND1
SCHEMBL29233673 0.82 CDK6 (0.56) CDK6PIM1CDK2CCNE1CDK1
SCHEMBL31472292 0.82 CDK6 (0.56) CDK6PIM1CDK2CCNE1CDK1
SCHEMBL31472288 0.79 CDK2 (0.66) CDK6PIM1CDK2CCNE1CDK1
SCHEMBL29233646 0.79 CDK2 (0.66) CDK6PIM1CDK2CCNE1CDK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-118184629-B Pyrimidine quinoxaline CDK inhibitor and preparation method and application thereof 中国药科大学 2025-02-07 CN disclosed